Budget Impact of Adopting Nirmatrelvir-Ritonavir for Treating COVID-19 in a Large Integrated Healthcare System - Top-Institutions - MDSpire

Budget Impact of Adopting Nirmatrelvir-Ritonavir for Treating COVID-19 in a Large Integrated Healthcare System

  • By

  • David P Bui

  • Denise M Hynes

  • Edwin Wong

  • Robert Vergun

  • Lei Yan

  • Yuli Li

  • Nallakkandi Rajeevan

  • Kristin Berry

  • Hung-Mo Lin

  • Yuan Huang

  • Diana J Govier

  • Mihaela Aslan

  • George Ioannou

  • Kristina L Bajema

  • September 24, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Veterans Health Administration (VHA)
    Veterans Health Administration (VHA)

    Washington, DC

    Key Differentiators

    • Infectious Diseases
    • Health Economics
    • Veteran Health Services Research

  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Health Economics
    • Clinical Epidemiology

  • #3

    Massachusetts General Hospital (MGH) / Harvard Medical School
    Massachusetts General Hospital (MGH) / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Infectious Diseases
    • Pharmacoeconomics
    • Health Services Research

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Infectious Diseases
    • Health Economics
    • Clinical Research

  • #5

    University of Washington School of Medicine
    University of Washington School of Medicine

    Seattle, WA

    Key Differentiators

    • Infectious Diseases
    • Health Economics
    • Epidemiology

Original Source(s)

Budget Impact of Adopting Nirmatrelvir-Ritonavir for Treating COVID-19 in a Large Integrated Healthcare System

  • by David P Bui, Denise M Hynes, Edwin Wong, Robert Vergun, Lei Yan, Yuli Li, Nallakkandi Rajeevan, Kristin Berry, Hung-Mo Lin, Yuan Huang, Diana J Govier, Mihaela Aslan, George Ioannou, Kristina L Bajema

  • September 24, 2025

Related Content

Hantavirus Outbreak Revives COVID-Era False Health Claims — The Monitor

COVID-19, Vaccines, and Retinal Vascular Disease

A global systematic review of 173 studies found differing associations between COVID-19 infection and vaccination and retinal vascular events, with retinal artery occlusion more common after infection and retinal vein occlusion more common after vaccination.

Recent COVID-19 Shot Linked to Less Spread

Protection against spread appeared strongest within 6 months of vaccination, while exposed vaccinated contacts showed no measurable reduction in infection risk.